Current status of engineered T-cell therapy for synovial sarcoma

Por Dallos, Matthew, Tap, William D, D’Angelo, Sandra P
Publicado no Immunotherapy (2016)

小细胞肺癌的的分子发病机制

Por D'ANGELO, Sandra P., Catherine PIETANZA, M., 李, 红洁, 李, 晓平
Publicado no Zhongguo Fei Ai Za Zhi (2010)

Cytokine release syndrome after radiation therapy: case report and review of the literature

Por Barker, Christopher A., Kim, Samuel K., Budhu, Sadna, Matsoukas, Konstantina, Daniyan, Anthony F., D’Angelo, Sandra P.
Publicado no J Immunother Cancer (2018)

Analysis of the Chemotherapy-Free Interval following Image-Guided Ablation in Sarcoma Patients

Por Sutton, Charles, Zhang, Yachao, Kim, DaeHee, Yarmohammadi, Hooman, Ziv, Etay, Boas, Franz E., Sofocleous, Constantinos T., Tap, William D., D'Angelo, Sandra P., Erinjeri, Joseph P.
Publicado no Sarcoma (2020)

Driver Mutations Determine Survival in Smokers and Never Smokers with Stage IIIB/IV Lung Adenocarcinomas

Por Paik, Paul K., Johnson, Melissa L., D’Angelo, Sandra P., Sima, Camelia S., Ang, Daphne, Dogan, Snjezana, Miller, Vincent A., Ladanyi, Marc, Kris, Mark G., Riely, Gregory J.
Publicado em 2012

Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor epidermal growth factor receptor (EGFR) mutations

Por Janjigian, Yelena Y., Park, Bernard J., Zakowski, Maureen F., Ladanyi, Marc, Pao, William, D’Angelo, Sandra P., Kris, Mark G., Shen, Ronglai, Zheng, Junting, Azzoli, Christopher G.
Publicado em 2011

Incidence of EGFR Exon 19 Deletions and L858R in Tumor Specimens From Men and Cigarette Smokers With Lung Adenocarcinomas

Por D'Angelo, Sandra P., Pietanza, M. Catherine, Johnson, Melissa L., Riely, Gregory J., Miller, Vincent A., Sima, Camelia S., Zakowski, Maureen F., Rusch, Valerie W., Ladanyi, Marc, Kris, Mark G.
Publicado em 2011

Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma: A Preplanned Interim Analysis of a Clinical Trial

Por D’Angelo, Sandra P., Russell, Jeffery, Lebbé, Céleste, Chmielowski, Bartosz, Gambichler, Thilo, Grob, Jean-Jacques, Kiecker, Felix, Rabinowits, Guilherme, Terheyden, Patrick, Zwiener, Isabella, Bajars, Marcis, Hennessy, Meliessa, Kaufman, Howard L.
Publicado no JAMA Oncol (2018)

Patient Experiences with Avelumab in Treatment-Naïve Metastatic Merkel Cell Carcinoma: Longitudinal Qualitative Interview Findings from JAVELIN Merkel 200, a Registrational Clinica...

Por Lambert, Jérémy, Marrel, Alexia, D’Angelo, Sandra P., Burgess, Melissa A., Chmielowski, Bartosz, Fazio, Nicola, Gambichler, Thilo, Grob, Jean-Jacques, Lebbé, Céleste, Robert, Caroline, Russell, Jeffrey, Güzel, Gülseren, Bharmal, Murtuza
Publicado no Patient (2020)

Molecular Epidemiology of EGFR and KRAS Mutations in 3026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-related KRAS-mutant Cancers

Por Dogan, Snjezana, Shen, Ronglai, Ang, Daphne C, Johnson, Melissa L, D’Angelo, Sandra P, Paik, Paul K, Brzostowski, Edyta B, Riely, Gregory J, Kris, Mark G, Zakowski, Maureen F, Ladanyi, Marc
Publicado em 2012

Is Repeat Pulmonary Metastasectomy Indicated for Soft Tissue Sarcoma?

Por Chudgar, Neel P., Brennan, Murray F., Tan, Kay See, Munhoz, Rodrigo R., D’Angelo, Sandra P., Bains, Manjit S., Huang, James, Park, Bernard J., Adusumilli, Prasad S., Tap, William D., Jones, David R.
Publicado no Ann Thorac Surg (2017)

Prevalence of tumor infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment

Por D’Angelo, Sandra P., Shoushtari, Alexander N., Agaram, Narasimhan P., Kuk, Deborah, Qin, Li-Xuan, Carvajal, Richard D., Dickson, Mark A., Gounder, Mrinal, Keohan, Mary Louise, Schwartz, Gary K., Tap, William D.
Publicado no Hum Pathol (2014)

A non-comparative multi-center randomized phase II study of nivolumab +/− ipilimumab for patients with metastatic sarcoma (Alliance A091401)

Por D’Angelo, Sandra P., Mahoney, Michelle R., Van Tine, Brian A., Atkins, James, Milhem, Mohammed M., Jahagirdar, Balkrishna N., Antonescu, Cristina R., Horvath, Elise, Tap, William D., Schwartz, Gary K., Streicher, Howard
Publicado no Lancet Oncol (2018)

Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation

Por Kadota, Kyuichi, Yeh, Yi-Chen, D’Angelo, Sandra P., Moreira, Andre L., Kuk, Deborah, Sima, Camelia S., Riely, Gregory J., Arcila, Maria E., Kris, Mark G., Rusch, Valerie W., Adusumilli, Prasad S., Travis, William D.
Publicado no Am J Surg Pathol (2014)

Langerhans-type dendritic cells electroporated with TRP-2 mRNA stimulate cellular immunity against melanoma: Results of a phase I vaccine trial

Por Chung, David J., Carvajal, Richard D., Postow, Michael A., Sharma, Sneh, Pronschinske, Katherine B., Shyer, Justin A., Singh-Kandah, Shahnaz, Dickson, Mark A., D'Angelo, Sandra P., Wolchok, Jedd D., Young, James W.
Publicado no Oncoimmunology (2017)

Alliance A091103 a phase II study of the angiopoietin 1 and 2 peptibody trebananib for the treatment of angiosarcoma

Por D’Angelo, Sandra P., Mahoney, Michelle R., Van Tine, Brian A., Adkins, Douglas R., Grosse Perdekamp, Maria T., Condy, Mercedes M., Luke, Jason J., Hartley, Eliza Woodward, Antonescu, Cristina R., Tap, William D., Schwartz, Gary K.
Publicado no Cancer Chemother Pharmacol (2015)

Phase 2 Trial of the CDK4 inhibitor Palbociclib (PD0332991) at 125 mg dose in Well-Differentiated or Dedifferentiated Liposarcoma

Por Dickson, Mark A., Schwartz, Gary K., Keohan, Mary Louise, D’Angelo, Sandra P., Gounder, Mrinal M., Chi, Ping, Antonescu, Cristina R., Landa, Jonathan, Qin, Li-Xuan, Crago, Aimee M., Singer, Samuel, Koff, Andrew, Tap, William D.
Publicado no JAMA Oncol (2016)

Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial

Por Kaufman, Howard L., Russell, Jeffery S., Hamid, Omid, Bhatia, Shailender, Terheyden, Patrick, D’Angelo, Sandra P., Shih, Kent C., Lebbé, Céleste, Milella, Michele, Brownell, Isaac, Lewis, Karl D., Lorch, Jochen H., von Heydebreck, Anja, Hennessy, Meliessa, Nghiem, Paul
Publicado no J Immunother Cancer (2018)

Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memor...

Por Horvat, Troy Z., Adel, Nelly G., Dang, Thu-Oanh, Momtaz, Parisa, Postow, Michael A., Callahan, Margaret K., Carvajal, Richard D., Dickson, Mark A., D'Angelo, Sandra P., Woo, Kaitlin M., Panageas, Katherine S., Wolchok, Jedd D., Chapman, Paul B.
Publicado no J Clin Oncol (2015)

Phase II Trial of the CDK4 Inhibitor PD0332991 in Patients With Advanced CDK4-Amplified Well-Differentiated or Dedifferentiated Liposarcoma

Por Dickson, Mark A., Tap, William D., Keohan, Mary Louise, D'Angelo, Sandra P., Gounder, Mrinal M., Antonescu, Cristina R., Landa, Jonathan, Qin, Li-Xuan, Rathbone, Dustin D., Condy, Mercedes M., Ustoyev, Yelena, Crago, Aimee M., Singer, Samuel, Schwartz, Gary K.
Publicado em 2013